Findings from a trial comparing the real-world effectiveness of asthma inhalers could reshape how children with asthma are treated.

Pittsburgh-based Highmark Health signed an outcomes-based contract with drugmaker AstraZeneca for its asthma and chronic obstructive pulmonary disease drug Symbicort. The contract will apply to ...